Zymergen Stock

zymergen.com/HealthcareFounded: 2013Funding to Date: $920.06MM

Zymergen is a developer of unique materials and products for a range of industries – from agriculture to electronics, consumer care to pharmaceuticals, and more.

Register for Details

For more details on financing and valuation for Zymergen, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Zymergen.

Register Today

Team

Management Team

Zach Serber
Chief Science Officer and Founder
Jack Gold
Chief Marketing Officer
Mina Kim
Chief Legal Officer
Jed Dean
VP of Operations and Engineering
Aaron Kimball
Chief Technical Officer
Richard Pieters
President, Products
Joshua Hoffman
Chief Executive Officer
Judy Gilbert
Chief People Officer
Enakshi Singh
VP of Finance

Board Members

Steven Chu
Stanford University
Deep Nishar
Soft Group International
Rohit Sharma
True Ventures
Jay T. Flatley
Illumina Inc
Matt Ocko
DCVC
Joshua Hoffman
Jed Dean
Sandra E. Peterson
Clayton, Dubilier & Rice, LLC

Other companies like Zymergen in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace.
NEW YORK, Oct. 03, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against...
SAN FRANCISCO, Sept. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses...